Flow Assurance Patent Landscape 2026
Flow assurance patenting is a concentrated, maturing field: BP Exploration Operating Co Ltd and Baker Hughes Co together account for the majority of activity among the top hundred filers, with hydrate inhibition chemistry dominating the technology mix. Annual volume has eased from its 2019 peak, and the field is entering a decline phase on a multi-year basis.
BP and Baker Hughes lead a concentrated but narrowing field
BP Exploration Operating Co Ltd holds the top position in the applicant ranking, followed closely by Baker Hughes Co and M I LLC. The top five filers together represent 39% of the hundred largest filers’ combined patent records, signalling a field where a small group of oilfield-services and energy majors set the direction.
The tier gap between the top two players and the rest is notable: BP Exploration Operating Co Ltd and Baker Hughes Co together substantially outpace the mid-tier, while the third-ranked filer (M I LLC) and below show meaningfully lower counts. Chinese institutions — Southwest Petroleum University and. China Petroleum & Chemical Corp — are the most active new entrants in recent periods.
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 1 | BP Exploration Operating Co Ltd | 14 | |
| 2 | Baker Hughes Co | 12 | |
| 3 | M I LLC | 7 | |
| 4 | CHINA PETROLEUM & CHEMICAL CORP | 5 | |
| 5 | Southwest Petroleum University | 4 | |
| 6 | UCL Business Ltd | 3 | |
| 7 | ChampionX USA Inc | 3 | |
| 8 | Exxon Production Research Co | 3 | |
| 9 | Akzo Nobel Chemicals International BV | 3 | |
| 10 | Dalian University of Technology | 3 |
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 11 | ISP Investments Inc | 2 | |
| 12 | Baker Hughes Oilfield Operations LLC | 2 | |
| 13 | Shenzhen Hongyi Marine Intelligent Equipment Co Ltd | 2 | |
| 14 | PetroChina Co Ltd | 2 | |
| 15 | Texas Tech University System | 2 | |
| 16 | Halliburton Energy Services Inc | 2 | |
| 17 | Beijing Waterput Environmental Technology Co Ltd | 2 | |
| 18 | KOREA ADVANCED INST OF SCI & TECH | 2 | |
| 19 | CHINA PETROLEUM & CHEM CO LTD OF NORTH BRANCH | 2 | |
| 20 | Guangzhou Institute of Energy Conversion, Chinese Academy of Sciences | 2 |
The leaders’ positions imply deep, long-running programs in hydrate and wax inhibition chemistry. Challengers entering now must either compete directly in crowded C09K chemistry or differentiate through adjacent routes such as pipeline transport engineering or polymer synthesis.
Filings from approximately the last 18–24 months are subject to publication lag and will undercount true activity; interpret recent-period data as a floor rather than a ceiling. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
A 2019 surge has given way to moderate, uneven activity; chemistry dominates the technology mix
The annual filing trend and the technology branch composition together reveal both the temporal trajectory of the field and the subjects attracting the most IP effort.
Annual filing trend
Filings spiked in 2019 (the peak year in evidence), then settled to a lower, irregular cadence through 2022–2025. The recent-window growth rate is negative, consistent with a declining phase. Data for 2024–2026 are subject to publication lag and should be read as incomplete floors.
↗ Hover for values · click a bar to ask EurekaTechnology composition
C09K (materials for miscellaneous applications, primarily chemical additives and inhibitors) is the dominant branch by a wide margin, reflecting the field’s strong emphasis on chemical treatment of hydrates, wax, and scale. E21B (earth and rock drilling / wells) and C10L (fuels and fuel additives) form a secondary tier. Pipeline transport (F17D), polymer chemistry (C08F), and analytical testing (G01N) are present but represent a small fraction of overall activity.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Polyaromatic hydrocarbon additives for hydrate inh…
Methods involving anti-agglomerant hydrate inhibitors and polyaromatic hydrocarbons for hydrate inhibition are provided. In some embodiments, the methods include introducing a hydrate inhibitor composition including an anti-agglomerant hydrate inhibitor into a fluid including (i) water and (ii) one of gas, liquid hydrocarbon, and any combination thereof… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Gas hydrate inhibition | 144 |
| 2 | Additives for hydrate inhibition in fluids gelled … | 47 |
| 3 | Hydrate inhibition | 43 |
| 4 | Hydrate inhibition | 38 |
| 5 | Hydrate inhibition | 34 |
| 6 | Hydrate inhibition | 30 |
| 7 | A method for inhibiting hydrate formation | 29 |
| 8 | Hydrate inhibition | 22 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the structure means for R&D investment decisions
Concentration, lifecycle stage, and the collaboration network each carry distinct implications for teams deciding where to focus or how to differentiate.
Field in decline: peak activity has passed
The lifecycle evidence places flow assurance in a Decline stage, with annual filing volume easing back from the 2019 peak. For R&D planners, this signals that incremental improvements to established hydrate-inhibitor chemistry face diminishing IP return. Investment rationale must shift toward novel mechanisms, adjacent application domains, or cost-reduction angles that existing incumbents have not yet addressed.
Lifecycle: DeclineTop five hold 39% share among the hundred largest filers
The top five applicants — BP Exploration Operating Co Ltd, Baker Hughes Co, M I LLC, China Petroleum & Chemical Corp, and Southwest Petroleum University — account for 39% of the hundred largest filers’ combined patent records. This level of concentration means that white space is relatively easier to find in sub-branches the leaders have not prioritized, but that any chemistry play in core C09K will face well-resourced prior art.
High concentrationChampionX–UCL Business partnership is the only significant co-filing relationship
The collaboration data identifies one substantive co-filing relationship: ChampionX USA Inc (listed as Multi Chem Group LLC in collaboration records) and UCL Business Ltd, sharing 5 joint filings. A secondary pairing between China Petroleum & Chemical Corp and Sinopec Research Institute of Safety Engineering Co Ltd accounts for 1 joint filing. The ecosystem is otherwise dominated by single-assignee filings, suggesting limited open-innovation activity and potential room for academic–industry partnerships.
Low collaboration densityChina leads in filing office activity; PCT and US are the key international routes
China is the leading filing jurisdiction by patent records, followed by the United States and WIPO (PCT). Canada and Europe (EPO) form a secondary tier. The China-heavy profile partly reflects active filings by Chinese national oil companies and universities, while PCT filings indicate that the leading international players are seeking broad geographic coverage for their most strategic assets.
China-led, PCT-enabledGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| ChampionX USA Inc | UCL Business Ltd | 5 |
| China Petroleum & Chemical Corp | Sinopec Research Institute of Safety Engineering Co Ltd | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
BP Exploration and Baker Hughes: chemistry-first incumbents with distinct downstream emphases
The two dominant filers share a core focus on C09K inhibitor chemistry but diverge meaningfully in their secondary technical routes, and their recent filing momentum differs from the new entrants now building positions.
BP Exploration Operating Co Ltd
Holding 14 patent records — the highest count in the ranking — BP Exploration Operating Co Ltd concentrates its portfolio in C09K materials (inhibitor chemistry), C10L fuel additive formulations, and related hydrocarbon treatment. The portfolio reflects a deep, long-standing program in chemical flow assurance rather than mechanical or monitoring solutions. No recent momentum signal is available in the evidence for this incumbent, consistent with a mature, established position rather than an accelerating one.
records: 14Baker Hughes Co
Baker Hughes Co holds 12 patent records and is the closest challenger. Its portfolio spans C09K inhibitor chemistry, E21B downhole well applications, and C10L fuel treatment — a broader technical footprint than BP’s, incorporating wellbore-intervention angles alongside chemistry. Like BP, Baker Hughes shows no recent accelerating momentum in the evidence, but its dual focus on chemistry and drilling/completion engineering gives it a differentiated claim on the downhole segment of flow assurance.
records: 12| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Southwest Petroleum University | 4 | ▲ new entrant |
| China Petroleum & Chemical Corp | 2 | ▲ new entrant |
Under-served branches adjacent to the dominant chemistry core
Several IPC branches appear in the flow assurance corpus with low patent-record counts relative to the dominant C09K cluster. These represent observations of relative sparsity; where technical value and a realistic entry path exist, they may warrant further investigation.
F17D · Pipeline transport systems
Pipeline transport (F17D) has 18 patent records — a meaningful presence but far below the C09K leader. The branch covers flow control hardware, pigging systems, and pipeline monitoring — mechanical and systems-level approaches to flow assurance that complement chemical inhibition. Dalian University of Technology and Akzo Nobel Chemicals International BV both hold positions here. An entry path exists via pipeline integrity monitoring or smart-pigging integration, areas where the chemical incumbents have limited coverage.
Search this in Eureka →G01N · Material analysis and testing
Analytical testing and characterization (G01N) has only 3 patent records in the corpus, making it the sparsest branch with plausible technical relevance. Real-time detection of hydrate nucleation, wax appearance temperature measurement, and online rheology monitoring are all under-served relative to the volume of inhibitor-chemistry filings. An entrant with sensor, spectroscopy, or digital-twin capabilities could occupy this adjacent space without competing head-on with the established chemistry players.
Search this in Eureka →How leaders diverge across technology routes
Route coverage across the main technology branches in the current evidence set.
| Player | C09K 8 · Materials for misc. applications | C10L 3 · Fuels & firelighters | E21B 37 · Earth & rock drilling (wells) | F17D 1 · Pipeline transport | C10L 1 · Fuels & firelighters |
|---|---|---|---|---|---|
| BP Exploration Operating Co Ltd | Strong · 14 | Strong · 13 | Moderate · 4 | Absent | Strong · 11 |
| Baker Hughes Co | Strong · 12 | Moderate · 6 | Strong · 9 | Absent | Absent |
| M I LLC | Strong · 8 | Absent | Moderate · 3 | Absent | Emerging · 1 |
| UCL Business Ltd | Strong · 5 | Strong · 3 | Strong · 4 | Absent | Absent |
| ChampionX USA Inc | Strong · 5 | Strong · 3 | Strong · 4 | Absent | Absent |
| Akzo Nobel Chemicals International BV | Strong · 3 | Strong · 3 | Absent | Strong · 3 | Moderate · 1 |
| Exxon Production Research Co | Strong · 3 | Strong · 3 | Absent | Absent | Absent |
Frequently asked questions
The analysis covers 46 patent families in scope, spanning hydrate inhibition chemistry, pipeline transport, wellbore treatment, and adjacent branches.
BP Exploration Operating Co Ltd leads the applicant ranking with 14 patent records, followed by Baker Hughes Co with 12 and M I LLC with 7.
The evidence places the field in a Decline stage: annual filing volume has eased back from a 2019 peak, and the recent-window growth rate is negative. The field is not growing on a multi-year basis.
C09K (materials for miscellaneous applications, covering chemical inhibitors and additives) is the dominant branch by a wide margin, reflecting the field’s strong focus on chemical hydrate, wax, and scale inhibition. E21B (drilling and wells) and C10L (fuels) form the secondary tier.
China is the leading filing jurisdiction by patent records, followed by the United States and WIPO (PCT). Canada and Europe (EPO) form a secondary tier, with several additional jurisdictions represented at lower counts.
The most active co-filing relationship in evidence is between ChampionX USA Inc and UCL Business Ltd, with 5 joint filings. A secondary pairing between China Petroleum & Chemical Corp and Sinopec Research Institute of Safety Engineering Co Ltd accounts for 1 joint filing. Beyond these two pairs, the field is dominated by single-assignee filings.
Ready to map your own flow assurance landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.